Passage Bio, Inc.
Nasdaq PASG · Philadelphia, PA
Works in Metabolic & endocrine · Neurology · Psychiatry
Passage Bio, Inc. is a clinical trial sponsor based in Philadelphia, PA, listed as Nasdaq PASG. It has 1 active clinical trial with 30 planned participants, in Metabolic & endocrine, Neurology and Psychiatry.
Trial track record · since 2021
Financials · Nasdaq PASG
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Passage Bio, Inc
Passage Bio, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 30 planned participants, in Metabolic & endocrine, Neurology, Psychiatry. Since 2021 it has completed 0 trials and stopped 0 early.
Passage Bio, Inc is based in Philadelphia, PA and is listed as Nasdaq PASG. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Passage Bio, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-05-15.
Approve Suite is not affiliated with Passage Bio, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.